Ocugen, Inc. (NASDAQ:OCGN) authorizes new $ 2.00 million share buyback program.
The press release noted that Ocugen believes its shares are significantly undervalued and this decision reflects Ocugens continued confidence in achieving its corporate goals and commitment to increasing value for its stockholders.
Based on previous trading day last sale of $1.28, the new program would allow the repurchase of 1.56 million shares.
According to the previous trading day last sale of OCGN was $1.28, representing a 4.92 % increase from the 52 week low of $1.22 and a 97.75 % decrease over the 52 week high of $57.00.
Ocugen, Inc. has a market capital of $10.07 million and is part of the Healthcare sector and Biotechnology industry.